Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2026
Employees
5,798
Stocks News & Analysis
stocks
Cheap Dividend Aristocrat has Fair Value raised after earnings
stocks
Why great earnings haven't been good enough for AI hardware stocks
stocks
Fair Value increased for Big 4 bank after earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,316.30 | 16.50 | -0.18% |
| CAC 40 | 8,650.56 | 24.38 | -0.28% |
| DAX 40 | 26,299.74 | 31.33 | -0.12% |
| Dow JONES (US) | 53,839.99 | 69.72 | 0.13% |
| FTSE 100 | 10,772.67 | 60.48 | -0.56% |
| HKSE | 25,195.55 | 200.96 | -0.79% |
| NASDAQ | 26,803.03 | 214.54 | 0.81% |
| Nikkei 225 | 68,808.35 | 499.76 | 0.73% |
| NZX 50 Index | 13,836.24 | 10.94 | 0.08% |
| S&P 500 | 7,798.99 | 50.49 | 0.65% |
| S&P/ASX 200 | 9,119.60 | 15.50 | -0.17% |
| SSE Composite Index | 3,921.25 | 5.71 | -0.15% |